893421-71-1 Usage
Description
2-(2-Bromothiophen-3-yl)ethanamine is a chemical compound with the molecular formula C6H7BrS. It is a derivative of thiophene, a five-membered aromatic ring containing sulfur. 2-(2-Bromothiophen-3-yl)ethanamine contains a bromine atom attached to the thiophene ring, along with an amine group attached to the ethyl chain. It is a versatile chemical with many potential applications in the field of chemistry and pharmaceuticals.
Uses
Used in Organic Synthesis:
2-(2-Bromothiophen-3-yl)ethanamine is used as a building block in various organic synthesis processes. Its unique structure allows it to be a valuable component in the creation of new compounds with specific properties.
Used in Medical Research:
2-(2-Bromothiophen-3-yl)ethanamine is used as a research tool in the development of new pharmaceuticals. Its chemical properties make it a promising candidate for the synthesis of potential drug molecules.
Used in Chemical Industry:
2-(2-Bromothiophen-3-yl)ethanamine is used in the chemical industry for the production of various chemical products. Its versatility and unique structure make it a valuable component in the synthesis of a wide range of compounds.
It is important to handle 2-(2-Bromothiophen-3-yl)ethanamine with care, as it can pose health and environmental risks if not properly handled and disposed of.
Check Digit Verification of cas no
The CAS Registry Mumber 893421-71-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,3,4,2 and 1 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 893421-71:
(8*8)+(7*9)+(6*3)+(5*4)+(4*2)+(3*1)+(2*7)+(1*1)=191
191 % 10 = 1
So 893421-71-1 is a valid CAS Registry Number.
893421-71-1Relevant articles and documents
NOVEL INDOLE AND PYRROLOPYRIDINE AMIDES
-
, (2012/09/11)
The present invention relates to indole and pyrrolopyridine amide derivatives of formula (I) wherein R1, R 2, R 3, U, V, W, X, Y, Z and ring A are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as orexin receptor antagonists.